Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
**Cymalon** is an over-the-counter oral urinary alkalinising product for short-term symptomatic relief of cystitis-associated dysuria in women. Each sachet contains sodium citrate dihydrate, citric acid anhydrous, sodium bicarbonate, and sodium carbonate; when dissolved in water, the formulation reduces urinary acidity and helps relieve burning, stinging, and irritation during urination. It is not an antibacterial treatment and does not eradicate an underlying urinary infection. The usual adult course is one sachet orally three times daily for two days.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Cymalon.